Drug: Cebranopadol: chronic pain clinical trials
Registry records that list "Drug: Cebranopadol" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
4
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
4 trials, 2 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain NCT07874620 | Not yet recruiting | Phase 2 | United States | Adneuris Therapeutics, Inc. | 2026-09 |
| A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain NCT07874620 | Not yet recruiting | Phase 2 | United States | Adneuris Therapeutics, Inc. | 2026-09 |
| CORAL XT - Open-label Extension Trial of the CORAL Trial NCT02031432 | Completed | Phase 3 | Austria, Belgium, Bulgaria, Denmark and 6 more | Tris Pharma, Inc. | 2013-12-18 |
| CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer NCT01964378 | Terminated | Phase 3 | Austria, Belgium, Bulgaria, Chile and 10 more | Tris Pharma, Inc. | 2013-10-29 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.